Chronic Low Grade Inflammation in Pathogenesis of PCOS
Open accessThe DOI matches its Crossref record; 97 of the 99 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is a one of the most common endocrine disorders, with a prevalence rate of 5–10% in reproductive aged women. It’s characterized by (1) chronic anovulation, (2) biochemical and/or clinical hyperandrogenism, and (3) polycystic ovarian morphology. PCOS has significant clinical implications and can lead to health problems related to the accumulation of adipose tissue, such as obesity, insulin resistance, metabolic syndrome, and type 2 diabetes. There is also evidence that PCOS patients are at higher risk of cardiovascular diseases, atherosclerosis, and high blood pressure. Several studies have reported the association between polycystic ovary syndrome (PCOS) and low-grade chronic inflammation. According to known data, inflammatory markers or their gene markers are higher in PCOS patients. Correlations have been found between increased levels of C-reactive protein (CRP), interleukin 18 (IL-18), tumor necrosis factor (TNF-α), interleukin 6 (IL-6), white blood cell count (WBC), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α) in the PCOS women compared with age- and BMI-matched controls. Women with PCOS present also elevated levels of AGEs and increased RAGE (receptor for advanced glycation end products) expression. This chronic inflammatory state is aggravating by obesity and hyperinsulinemia. There are studies describing mutual impact of hyperinsulinemia and obesity, hyperandrogenism, and inflammatory state. Endothelial cell dysfunction may be also triggered by inflammatory cytokines. Many factors involved in oxidative stress, inflammation, and thrombosis were proposed as cardiovascular risk markers showing the endothelial cell damage in PCOS. Those markers include asymmetric dimethylarginine (ADMA), C-reactive protein (CRP), homocysteine, plasminogen activator inhibitor-I (PAI-I), PAI-I activity, vascular endothelial growth factor (VEGF) etc. It was also proposed that the uterine hyperinflammatory state in polycystic ovary syndrome may be responsible for significant pregnancy complications ranging from miscarriage to placental insufficiency. In this review, we discuss the most importance evidence concerning the role of the process of chronic inflammation in pathogenesis of PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“COCs also exacerbate the inflammatory state present in these patients, which is likely related to increased aldosterone–renin ratio and CRP [12,14].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredIn the citing paper
“The release of inflammatory markers is associated with long-term metabolic complications and high cardiovascular risk [12].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · cited 1×
“Compared with control women, patients with PCOS presented higher circulating concentrations of markers such as homocysteine, asymmetric dimethylarginine, and increased superoxide dismutase activity and decreased glutathione levels and paraoxonase-1 activity [2].”
BackgroundMacrophage-mediated inflammation in metabolic disease
Chawla, A., Nguyen, K. D., & Goh, Y. P. S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3071 · Cited by 1,314
Adapting to obesity with adipose tissue inflammation
Reilly, S. M., & Saltiel, A. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.90 · Cited by 1,204
Chronic Inflammation in Obesity and the Metabolic Syndrome
Monteiro, R., & Azevedo, I. (2010) · Mediators of Inflammation · doi:10.1155/2010/289645 · Cited by 1,186 · cited 1×
“Obesity is a metabolic condition characterized by chronic inflammation state with higher pro-inflammatory cytokines, chemokines, and oxidative stress (OS) markers levels [5,6].”
BackgroundChronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
Metabolic Inflammation and Insulin Resistance in Obesity
Wu, H., & Ballantyne, C. M. (2020) · Circulation Research · doi:10.1161/circresaha.119.315896 · Cited by 1,059
Cited by
Items 501–600 of 731
Manifestações endocrinológicas e dermatológicas da SOP em gestantes
Viégas, J. D. V. O., Batista, M. L. M. B., Ribeiro, C. D. L. L., Guimarães, A. C. C. M., Cavalcante, A. F. C., Tavares, L. F. D. A., Tourinho, M. M. D. S., Crusius, D. V. D. S., de Pinho, L. A., Zanoni, R. D., et al. (2023) · Seven International Medical and Nursing Congress · doi:10.56238/iicongressmedicalnursing-076 · Cited by 1
Effects of Acupuncture Treatment on Polycystic Ovary Syndrome (PCOS)
Ramanathan, G. (2023) · Obstetrics and gynecology. · doi:10.5772/intechopen.113799 · Cited by 2
Skrypnik, K., Pluta, D., Wójtowicz, M. K., Rhaiem, T. B., & Suliburska, J. (2024) · Ginekologia Polska · doi:10.5603/gpl.98015 · Cited by 1
Sirotkin, A. V., Fabová, Z., Loncová, B., & Harrath, A. H. (2024) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2024.106856 · Cited by 1
Poznyak, A. V., Khotina, V. A., Khotina, V. A., Sukhorukov, V. N., Sukhorukov, V. N., Kovyanova, T. I., Kovyanova, T. I., Starodubtseva, I. A., Elizova, N. V., Churov, A. V., et al. (2024) · OnLine Journal of Biological Sciences · doi:10.3844/ojbsci.2025.10.21 · Cited by 1
ANIMAL MODELS AND MECHANISM OF ACTION OF POLYCYSTIC OVARIAN SYNDROME: A REVIEW
Sharma, D., Ruhi, B., & Bhatia, D. S. (2024) · INDIAN DRUGS · doi:10.53879/id.61.09.14433 · Cited by 1
Metformin dosage and galectin-3 levels: insights from PCOS patients preparing for IVF
Nikolic, V. N., Stefanović, M., Mitić, D., Sunaric, S. M., Stojiljković, V., Trajković, H., Ignjatović, A., & Stokanović, D. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1505022 · Cited by 1
Yüce, H., Türkmen, N. B., Aydın, M., Taşlıdere, A., ÖZEK, D. A., Şenkal, S., Aslan, S., Doğan, A., Çiftçi, O., & Ünüvar, S. (2025) · Biotechnic & Histochemistry · doi:10.1080/10520295.2025.2586701 · Cited by 1
Tang, H., Ouyang, X., Chong, X. E., Yang, Y., Fu, J., Zhou, Q., & Li, L. (2026) · Current Pharmaceutical Design · doi:10.2174/0113816128423816251229112509 · Cited by 1
Song, J., Feng, D., Na, Z., Yang, H., Peng, Y., Li, P., Shi, B., & Li, D. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4165608 · Cited by 1
Zheng, Z., Wang, Y., & Liu, X. (2023) · Research Square · doi:10.21203/rs.3.rs-3704976/v1 · Cited by 1
Jialal, I. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab935
CORRELATION BETWEEN INFLAMATORY CYTOKINES AND ANTHROPOLOGICAL PARAMETERS IN THE AGED POPULATION
Jgharkava, M., Orjonikidze, N., KARANADZE, N., Chikovani, T., & Pantsulaia, I. (2022) · EXPERIMENTAL & CLINICAL MEDICINE GEORGIA · doi:10.52340/jecm.2022.03.11
Polycystic ovarian syndrome and reproductive failure
Duero, J., & Tal, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90805-4.00009-2
Ibraheem, R. S., Tektook, N. K., & Hussain, D. S. S. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s03.097 · Cited by 1
Thambiraj, G. (2023) · International Journal of Ayurveda and Pharma Research · doi:10.47070/ijapr.v11i1.2661
Akciğer Kanserine Moleküler Terapötik Yaklaşım
Bayrak, B. Y. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub80.c356
Hematolojik Malignitelerde Sitogenetiğin Tanısal ve Terapötik Yönleri
Şahin, H. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub80.c359
THE EFFECT AND SAFETY OF BERBERINE ON POLYCYSTIC OVARY SYNDROME : A SYSTEMATIC REVIEW
Alicia, D. N. R. (2023) · Journal of Advance Research in Medical & Health Science · doi:10.53555/nnmhs.v9i5.1683
Research Progress of Polycystic Ovary Syndrome Complicated with Insulin Resistance
马, 红. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1371583
Jihad, A. T., & Sarhat, E. R. (2023) · South Asian Research Journal of Pharmaceutical Sciences · doi:10.36346/sarjps.2023.v05i04.005
Beyazıt, F., Hız, M. M., Türkön, H., Unsal, M. A., & Pek, E. (2023) · The Annals of Clinical and Analytical Medicine · doi:10.4328/acam.21638
Сytokines as non-hormonal regulators in the pathogenesis of endocrinopathies
Valikova, O. V., Здор, В. В., Sarychev, V. A., Tikhonov, Y. N., & Boroda, A. V. (2023) · Russian Journal of Immunology · doi:10.46235/1028-7221-13959-can
Perspectives of PCOS Pathophysiology: Exploring the Interplay between PCOS and the Gut Microbiota
Khade, K., Dadachanji, R., & Mukherjee, S. (2023) · Journal of Endocrinology & Reproduction · doi:10.18311/jer/2023/34986
ANTIOKSIDANTŲ VAIDMUO BEI ĮTAKA REUMATOIDINIAM ARTRITUI IR POLICISTINIŲ KIAUŠIDŽIŲ SINDROMUI
Paškevičienė, M., & Petrauskaitė, I. (2023) · Health Sciences · doi:10.35988/sm-hs.2023.260
Chen, X., Zhang, W., Ma, Y., Chen, Y., & Xu, B. (2023) · Research Square · doi:10.21203/rs.3.rs-3497666/v1
Cell-molecular immune mechanisms in the pathogenesis of polycystic ovarian syndrome
Valikova, O. V., & Здор, В. В. (2023) · Cytokines and inflammation · doi:10.17816/ci2022221-4-2
Kabakchieva, P. (2023) · Anti-Aging Eastern Europe · doi:10.56543/aaeeu.2023.2.3.02 · Cited by 1
Al-Ardi, M. H. (2023) · International Journal of Applied and Scientific Research · doi:10.59890/ijasr.v1i4.1047
Lin, R., Wang, J., Fu, W., Tuo, S., Ran, J., Shao, Y., & Shao, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-3878317/v1
岳, 玺. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.142635
Chimplee, K., Wongpia, I., Paengneewong, A., & Charoenpanyavicha, P. (2024) · Biomedical Sciences and Clinical Medicine · doi:10.12982/bscm.2024.05 · Cited by 1
Polikistik Over Sendromunda Besinlerle Alınan İleri Glikasyon Son Ürünlerinin Rolü
Özdemir, M., & Bilgiç, P. (2024) · İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi · doi:10.38079/igusabder.1327059
Causes of Polycystic Ovarian Syndrome
Panda, S., Das, R., Konar, L., & Singh, M. (2024) · Obstetrics and gynecology. · doi:10.5772/intechopen.113877
Nature's Remedy: Exploring Herbal Treatments for Polycystic Ovarian Syndrome
Attri, M., Raghav, A., & Chaudhary, H. (2024) · Current Nutraceuticals · doi:10.2174/0126659786282036240503112128 · Cited by 1
Shirvanizadeh, F., Eidi, A., Hafezi, M., & Eftekhari‐Yazdi, P. (2024) · Qur̓ān/pizhūhī-i khāvar/shināsān · doi:10.61186/iau.34.2.155
Role of seed cycling diet during menstrual dysfunction
Priyanka, Sangwan, V., Rani, R., Yadav, R., & Bajal, N. (2024) · International Journal of Agriculture Extension and Social Development · doi:10.33545/26180723.2024.v7.i7sb.779
Roy, M., Mazumder, R., Singh, N., Bhardwaj, S., Mishra, R., Mishra, R., & Kumar, B. (2024) · Current Drug Therapy · doi:10.2174/0115748855313334240827071434
Sharma, P., Mittal, P., & Arya, G. C. (2024) · Current Analytical Chemistry · doi:10.2174/0115734110312022240903060337
Ghannawi, L. A., Al-Khafajii, G. S., Gharab, K. M. K., Shakir, O. Y., & Thamer, M. A. (2024) · Mağallaẗ al-tarbiyaẗ wa-al-ʻilm · doi:10.33899/edusj.2024.151393.1477
Kadhim, R. S., & Hassan, F. A. (2024) · AIP conference proceedings · doi:10.1063/5.0236227
Research Progress on Polycystic Ovary Syndrome and Epigenetic DNA Methylation Regulation
蔡, 灵. (2025) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2025.151022
Research Progress on the Polycystic Ovary Syndrome with Kidney-Deficiency Type
康, 馨. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.152557
Hassan, Z. A., & Ghafil, N. Y. (2025) · Journal of Neonatal Surgery · doi:10.52783/jns.v14.1964
Afridi, S., Noor, S., Shah, S. J., Tariq, E., Razaq, M., & Saifullah, S. (2025) · Pakistan Journal of Health Sciences · doi:10.54393/pjhs.v6i3.2920
The Model of Ramadan Diurnal Intermittent Fasting: Unraveling the Health Implications, volume III
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-6263-5
Mohammed, Z. G., & Farman, H. A. (2025) · Precision Nanomedicine · doi:10.33218/001c.137511
Wang, Y., Tian, Y., Zhou, F., & Zhong, Z. (2025) · PLoS ONE · doi:10.1371/journal.pone.0320526
Zhao, S. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2025.au22999
洪, 雯. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1551542
Jain, A., Poyya, J., Neravi, A., Sunil Kumar, K. S., & Oli, A. K. (2025) · Natural Resources for Human Health · doi:10.53365/nrfhh/203184
Soni, A., Parikh, M., & Gandhi, T. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00013-9
Patil, M., Hedaoo, R. P., Bhattacharjee, B., Kuthiala, R., & Ching, S. M. (2025) · South Eastern European Journal of Public Health · doi:10.70135/seejph.vi.6313
Addressing a Key Metabolic Component of PCOS: Insulin
Hopkins, D., & Chappell, A. (2025) · Obstetrics and gynecology. · doi:10.5772/intechopen.1010981
Polycystás ovarium szindrómás betegek életminőségét vizsgáló kérdőív magyar nyelvű adaptációja
Nagy, V., & Papp-Zipernovszky, O. (2025) · Orvosi Hetilap · doi:10.1556/650.2025.33312
Guo, Q., Zhou, Y., Li, L., Chen, X., & Sun, L. T. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2530571
Yafei, X., Zhang, Z., Zhao, Y., Zhang, J., & Yin, Q. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s534136
Seßenhausen, P., Caban, K. M., Schneider, M., Eubler, K., Kreitmair, N., Schneider, J., Dissen, G. A., Berg, D., Berg, U., Stöckl, J. B., et al. (2025) · Biology of Reproduction · doi:10.1093/biolre/ioaf196
Elevated level of platelet factor 4 in follicular fluid is associated with polycystic ovary syndrome
Wang, W., Wang, G., Niu, X., Li, Z., Zhang, M., Xu, Z., & Liu, T. (2025) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2025.111009
Wang, P., Sun, X., Sun, J., & Deng, F. (2025) · Pharmacognosy Magazine · doi:10.1177/09731296251362995
Dey, A., Das, S., Rosas, I. M., Ray, S. D., Najmi, A. A., Das, M., Ghosh, M., Yasmin, A., Ghosh, A., Sen, S., et al. (2025) · Journal of Computational Biophysics and Chemistry · doi:10.1142/s2737416526500158
Wang, H., Chen, Y., Wang, Q., Xu, S., & Wu, X. (2025) · Endocrine Connections · doi:10.1530/ec-25-0608
«Metabolic health» and endothelial function in women with polycystic ovary syndrome
Tsar’kova, A. V., Balan, V. E., Orazov, M. R., Тихомирова, Е. В., Orlova, S. A., Сергеевна, Ж. А., & Titchenko, Y. P. (2025) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20252505127
Kou, X., & Xiao, J. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s531967 · Cited by 1
Jiang, P., Wu, L., & Han, H. (2025) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2025-0228
刘, 甜. (2025) · Asian Case Reports in Emergency Medicine · doi:10.12677/acrem.2025.134057
Muhlida, V. I., & Kurniawati, E. Y. (2025) · Agribiohealth (Journal of Agriculture Biology & Health Sciences) · doi:10.65318/agribiohealth.v1i2.17 · Cited by 1
Proinflammatory markers in women with type 1 diabetes and polycystic ovary syndrome
García-Sáenz, M. R., López-Juárez, N., Valencia‐Ortega, J., Saucedo, R., Lobaton-Ginsberg, M., Ramírez‐Rentería, C., León-Wu, K. S., Sosa, E., Espinosa-Cárdenas, E., & Ferreira‐Hermosillo, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-25070-9
Qu, J., & Zhang, L. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s566694
Dong, X., Xie, F., & Li, P. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s569044
Mavulati, S. C., & Dodoala, S. (2025) · Biotechnologia · doi:10.5114/bta/214378
Ji, X.-L., Cui, Q. C., Lei, L.-Z., Zhang, J., & Li, Y. (2025) · Reproductive and Developmental Medicine · doi:10.1097/rd9.0000000000000148
Zou, L., Li, W., Xu, D., Zhu, S., & Jiang, B. (2023) · Figshare · doi:10.6084/m9.figshare.23902857
Kong, F.-S., Feng, J., Yao, J.-P., Lu, Y., Guo, T., Sun, M., Ren, C.-Y., Jin, Y.-Y., Ma, Y., & Chen, J. (2024) · Figshare · doi:10.6084/m9.figshare.26731570
Shang, J., Wang, S., Wang, A., Li, F., Zhang, J., Wang, J., Lv, R., Chen, H., Mu, X., Zhang, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24987789
Kong, F.-S., Feng, J., Yao, J.-P., Lu, Y., Guo, T., Sun, M., Ren, C.-Y., Jin, Y.-Y., Ma, Y., & Chen, J. (2024) · Figshare · doi:10.6084/m9.figshare.26731558
Kong, F.-S., Feng, J., Yao, J.-P., Lu, Y., Guo, T., Sun, M., Ren, C.-Y., Jin, Y.-Y., Ma, Y., & Chen, J. (2024) · Figshare · doi:10.6084/m9.figshare.26731579
Zhou, L., Qu, H., Yang, L., & Shou, L. (2024) · Figshare · doi:10.6084/m9.figshare.26637207
Kong, F.-S., Feng, J., Yao, J.-P., Lu, Y., Guo, T., Sun, M., Ren, C.-Y., Jin, Y.-Y., Ma, Y., & Chen, J. (2024) · Figshare · doi:10.6084/m9.figshare.26731564
Kong, F.-S., Feng, J., Yao, J.-P., Lu, Y., Guo, T., Sun, M., Ren, C.-Y., Jin, Y.-Y., Ma, Y., & Chen, J. (2024) · Figshare · doi:10.6084/m9.figshare.26731588
Zou, L., Li, W., Xu, D., Zhu, S., & Jiang, B. (2023) · Figshare · doi:10.6084/m9.figshare.23902860
Kong, F.-S., Feng, J., Yao, J.-P., Lu, Y., Guo, T., Sun, M., Ren, C.-Y., Jin, Y.-Y., Ma, Y., & Chen, J. (2024) · Figshare · doi:10.6084/m9.figshare.26731582
Kong, F.-S., Feng, J., Yao, J.-P., Lu, Y., Guo, T., Sun, M., Ren, C.-Y., Jin, Y.-Y., Ma, Y., & Chen, J. (2024) · Figshare · doi:10.6084/m9.figshare.26731576
Kong, F.-S., Feng, J., Yao, J.-P., Lu, Y., Guo, T., Sun, M., Ren, C.-Y., Jin, Y.-Y., Ma, Y., & Chen, J. (2024) · Figshare · doi:10.6084/m9.figshare.26731567
Kong, F.-S., Feng, J., Yao, J.-P., Lu, Y., Guo, T., Sun, M., Ren, C.-Y., Jin, Y.-Y., Ma, Y., & Chen, J. (2024) · Figshare · doi:10.6084/m9.figshare.26731573
Kong, F.-S., Feng, J., Yao, J.-P., Lu, Y., Guo, T., Sun, M., Ren, C.-Y., Jin, Y.-Y., Ma, Y., & Chen, J. (2024) · Figshare · doi:10.6084/m9.figshare.26731561
Zhou, J., Mo, H., Feng, Q., Li, L., & La, J. (2024) · Figshare · doi:10.6084/m9.figshare.26616385
Yan, S., Gao, Z., Ding, J., Chen, S., Wang, Z., Jin, W., Qu, B., Zhang, Y., Yang, L., Guo, D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26637024
Kong, F.-S., Feng, J., Yao, J.-P., Lu, Y., Guo, T., Sun, M., Ren, C.-Y., Jin, Y.-Y., Ma, Y., & Chen, J. (2024) · Figshare · doi:10.6084/m9.figshare.26731585
Metabolic health outcomes among women with polycystic ovary syndrome
Kumarendran, B. (2024) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 3
CELA, E. (2025) · IRIS Research product catalog (Sapienza University of Rome)
李, 语. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15123547
Piórkowska, N., Bizoń, A., Bizon, K., & Franik, G. (2025) · medRxiv · doi:10.64898/2025.12.23.25342888
Andaç, B., Başaran, M. N., & Eren, G. N. (2026) · The European Research Journal · doi:10.18621/eurj.1815977
Fertility Support of PCOS with Machine Learning
Suresh, M. X., Ganeshan, R., Babar, A., Shaqadan, A. A., & Sabarna, K. (2025) · Studies in systems, decision and control · doi:10.1007/978-3-031-87584-7_219 · Cited by 1
Rambaran, N., & Islam, M. S. (2026) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-3612-2_8
Machine Learning-Based Detection of PCOS by Identifying Key Contributing Factors
Sree, R. A., Divyadarshini, R., Jothika, R. M., & Tamilselvi, P. (2026) · Lecture notes in networks and systems · doi:10.1007/978-981-95-1320-8_31
Relationship between leptin receptor and TNF-α in obesity and polycystic ovary syndrome
Attia, O. M., & Abdelmoaty, A. A. A. (2025) · Asia-Pacific Journal of Surgical & Experimental Pathology · doi:10.32948/ajsep.2025.06.20
Metadata
- Authors
- Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B.
- Affiliations
- Medical University of Warsaw (PL)
- Warsaw University of Life Sciences (PL)
- Department of Gynaecological Endocrinology, Poznan University of Medical Sciences, 60-535 Poznan, Poland
- Corresponding author
- Rudnicka, Ewa
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-04-06
- Volume
- 22
- Issue
- 7
- Pages
- 3789
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8038770
- OpenAlex
- W3145310045
- Cited by
- 680
- References
- 99
- Citations by year
- 2026: 152 · 2025: 172 · 2024: 165 · 2023: 112 · 2022: 74 · 2021: 5
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- polycystic ovary syndrome, low-grade inflammation, inflammatory cytokines, C-reactive protein, advanced glycation end products, RAGE, hyperinsulinemia, obesity, endothelial dysfunction, oxidative stress, cardiovascular risk, pregnancy complications, hyperandrogenism, insulin resistance
- MeSH terms
- Aging, C-Reactive Protein, Chronic Disease, Diabetes Mellitus, Type 2, Female, Humans, Inflammation, Obesity, Polycystic Ovary Syndrome, Cytokines, Metabolic Syndrome, Endothelial Cells, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.